126 related articles for article (PubMed ID: 25220599)
1. Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
Tainsky MA
Biochim Biophys Acta; 2009 Dec; 1796(2):176-93. PubMed ID: 19406210
[TBL] [Abstract][Full Text] [Related]
2. The identification of human tumour antigens: Current status and future developments.
Miles AK; Matharoo-Ball B; Li G; Ahmad M; Rees RC
Cancer Immunol Immunother; 2006 Aug; 55(8):996-1003. PubMed ID: 16408215
[TBL] [Abstract][Full Text] [Related]
3. The path to routine use of genomic biomarkers in the cancer clinic.
Boutros PC
Genome Res; 2015 Oct; 25(10):1508-13. PubMed ID: 26430161
[TBL] [Abstract][Full Text] [Related]
4. Functional proteomic biomarkers in cancer.
Larijani B; Perani M; Alburai'si K; Parker PJ
Ann N Y Acad Sci; 2015 Jun; 1346(1):1-6. PubMed ID: 25801208
[TBL] [Abstract][Full Text] [Related]
5. Single-cell analysis tools for drug discovery and development.
Heath JR; Ribas A; Mischel PS
Nat Rev Drug Discov; 2016 Mar; 15(3):204-16. PubMed ID: 26669673
[TBL] [Abstract][Full Text] [Related]
6. Genomic biomarkers: Unveiling the potential for precise cancer therapy response.
Kaur G; Pahwa P; Prakash A; Medhi B
Indian J Pharmacol; 2023; 55(4):213-215. PubMed ID: 37737072
[No Abstract] [Full Text] [Related]
7. Cancer biomarkers: Clinical aspects & laboratory determination.
Gupta SK
Indian J Med Res; 2023 Nov; 158(5&6):565-566. PubMed ID: 38265948
[No Abstract] [Full Text] [Related]
8. Validation of new cancer biomarkers: a position statement from the European group on tumor markers.
Duffy MJ; Sturgeon CM; Sölétormos G; Barak V; Molina R; Hayes DF; Diamandis EP; Bossuyt PM
Clin Chem; 2015 Jun; 61(6):809-20. PubMed ID: 25882892
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic clinical genome and exome sequencing.
Virani A; Austin J
N Engl J Med; 2014 Sep; 371(12):1169-70. PubMed ID: 25229937
[No Abstract] [Full Text] [Related]
10. Mass spectrometry-based proteomics as an emerging tool in clinical laboratories.
Birhanu AG
Clin Proteomics; 2023 Aug; 20(1):32. PubMed ID: 37633929
[TBL] [Abstract][Full Text] [Related]
11. Circulating Exosome Cargoes Contain Functionally Diverse Cancer Biomarkers: From Biogenesis and Function to Purification and Potential Translational Utility.
Mitchell MI; Ma J; Carter CL; Loudig O
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884411
[TBL] [Abstract][Full Text] [Related]
12. Effects of Cancer Presence and Therapy on the Platelet Proteome.
Walraven M; Sabrkhany S; Knol JC; Dekker H; de Reus I; Piersma SR; Pham TV; Griffioen AW; Broxterman HJ; Oude Egbrink M; Verheul HMW; Jimenez CR
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361002
[TBL] [Abstract][Full Text] [Related]
13. Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.
Zolotovskaia MA; Sorokin MI; Emelianova AA; Borisov NM; Kuzmin DV; Borger P; Garazha AV; Buzdin AA
Front Pharmacol; 2019; 10():1. PubMed ID: 30728774
[TBL] [Abstract][Full Text] [Related]
14. Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer.
Song E; Gao Y; Wu C; Shi T; Nie S; Fillmore TL; Schepmoes AA; Gritsenko MA; Qian WJ; Smith RD; Rodland KD; Liu T
Sci Data; 2017 Jul; 4():170091. PubMed ID: 28722704
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial protocol to treat massive Africanized honeybee (
Barbosa AN; Boyer L; Chippaux JP; Medolago NB; Caramori CA; Paixão AG; Poli JPV; Mendes MB; Dos Santos LD; Ferreira RS; Barraviera B
J Venom Anim Toxins Incl Trop Dis; 2017; 23():14. PubMed ID: 28331487
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in mass spectrometry-based proteomics of gastric cancer.
Kang C; Lee Y; Lee JE
World J Gastroenterol; 2016 Oct; 22(37):8283-8293. PubMed ID: 27729735
[TBL] [Abstract][Full Text] [Related]
17. Advances in targeted proteomics and applications to biomedical research.
Shi T; Song E; Nie S; Rodland KD; Liu T; Qian WJ; Smith RD
Proteomics; 2016 Aug; 16(15-16):2160-82. PubMed ID: 27302376
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
[TBL] [Abstract][Full Text] [Related]
19. Towards identification of true cancer biomarkers.
Diamandis EP
BMC Med; 2014 Sep; 12():156. PubMed ID: 25220599
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
